You searched for metabolic diseases - Page 32 of 64

News and Trends 1 Mar 2019

Rapid Response mRNA Vaccine Facility Gets €30M Funding

…emerging diseases. CureVac is a company that develops vaccines made of mRNA, a molecule that lets cells translate genes into proteins. The company’s drug candidates deliver mRNA molecules to cells…

March 1, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 26 Sep 2022

Kupando raises €13M in series A funding round led by Remiges Ventures

…immunity for use in oncology and infectious diseases. Kupando says it will use the funds to complete IND-enabling work and to initiate the clinical development its lead candidate, KUP101 in…

September 26, 2022 - 2 minutesmins - By Liza Laws

Best in Biotech 24 Oct 2024

Six biotech companies advancing multiple sclerosis therapies

…its potential to treat autoimmune disorders, too. This is what Kyverna Therapeutics is focusing on, as it is attempting to develop cell therapies for patients suffering from B-cell-driven autoimmune diseases….

October 24, 2024 - 8 minutesmins - By Willow Shah-Neville

News and Trends 29 Aug 2022

Grid Biosciences signs agreement with NIH for Epstein-Barr virus vaccine

…diseases associated with EBV. EBV is the causative agent of infectious mononucleosis and is associated with certain malignancies and autoimmune diseases, such as nasopharyngeal carcinoma, gastric cancer, Hodgkin’s Lymphoma, Burkitt’s…

August 29, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 9 Jun 2025

First antibiotic in 50 years to tackle superbug nears approval: what’s going on in the field?

…battling infectious diseases? Table of contents Roche’s antibiotic zosurabalpin to enter phase 3 trials Swiss drug maker Roche hit the headlines when it announced that it is advancing the development…

June 9, 2025 - 11 minutesmins - By Roohi Mariam Peter

Best in Biotech 28 Jan 2019

5 Real-Life Technologies Where Biotech Meets Science Fiction

…world routinely modify the DNA of worms, fruit flies, zebrafish, mice, and many others to replicate and study human diseases. Genetically modified mosquitoes are being used to prevent the spread…

January 28, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

More News! 17 Jul 2024

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

…series C round led by Novo Holdings. Asceneuron is focused on developing therapeutics for neurodegenerative diseases and the funds will accelerate the development of their lead asset, ASN51, a promising…

July 17, 2024 - 10 minutesmins - By Jules Adam

News and Trends 1 Dec 2023

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

…conditions and rare cardiac muscle diseases. AnaptysBio to acquire BDCA2 modulator antibody portfolio from Centessa Pharmaceuticals Immunomodulators are designed to treat autoimmune and inflammatory diseases by modifying the immune system…

December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter

In Depth 18 Feb 2025

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

…to recognize and kill harmful cells, be it tumor cells in the case of cancer or autoreactive cells in the case of autoimmune diseases. They achieve this by binding to…

February 18, 2025 - 10 minutesmins - By Roohi Mariam Peter

More News! 14 Nov 2022

BioSenic’s autoimmune disease platform adapting to meet unmet medical needs

…specializes in serious autoimmune and inflammatory diseases as well as cell repair. The update follows the announcement of the merger between Bone Therapeutics and Medsenic and the listing on Euronext…

November 14, 2022 - 4 minutesmins - By Liza Laws

News and Trends 21 Nov 2017

French Biotech Steps Up Autoimmune Disease Drug Development with €14.5M Series A

Step Pharma will use the proceeds of its first fundraising round to support the development of immunomodulators for autoimmune diseases towards the clinic. Step Pharma develops inhibitors targeting an enzyme…

November 21, 2017 - 3 minutesmins - By Alex Dale

In Depth 18 Sep 2024

Two targets, one solution: The rise of bispecific antibodies

…incidences of chronic diseases such as cancer, autoimmune disorders, and infectious diseases, rising demand for targeted therapies, as well as advancements in antibody engineering technologies, as being some of the…

September 18, 2024 - 9 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Rapid Response mRNA Vaccine Facility Gets €30M Funding

Kupando raises €13M in series A funding round led by Remiges Ventures

Six biotech companies advancing multiple sclerosis therapies

Grid Biosciences signs agreement with NIH for Epstein-Barr virus vaccine

First antibiotic in 50 years to tackle superbug nears approval: what’s going on in the field?

5 Real-Life Technologies Where Biotech Meets Science Fiction

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered

T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments

BioSenic’s autoimmune disease platform adapting to meet unmet medical needs

French Biotech Steps Up Autoimmune Disease Drug Development with €14.5M Series A

Two targets, one solution: The rise of bispecific antibodies

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!